Anupam Rasayan India approves allotment of 19, 04,540 shares
General

Anupam Rasayan India approves allotment of 19, 04,540 shares

These Equity Shares shall rank pari-passu, in all respects, with the existing equity shares of the company

  • By ICN Bureau | December 19, 2023

The Board of Directors of Anupam Rasayan India Limited had approved the allotment of 19, 04,540 equity shares of face value of Rs. 10/- each fully paid-up at a price of Rs. 945.11 per equity share to Rehash Industrial and Resins Chemicals Private Limited, a promoter of the company, on a preferential basis, based on the approval of the members of the company.

These Equity Shares shall rank pari-passu, in all respects, with the existing equity shares of the company.

The company has received In-principle approval from BSE Limited and National Stock Exchange of India Limited for issue of the aforesaid Equity Shares on preferential basis, vide letters dated December 05, 2023. The application for listing and trading approval of the stock exchanges for the Equity Shares allotted as above, will be made in due course.

Post the above allotment, the issued, subscribed and paid-up equity share capital of the Company shall stand increased to Rs. 1,09,51,52,280 comprising of 10, 95, 15,228 Equity Shares of Rs. 10/- each fully paid.

Register Now to Attend NextGen Chemicals & Petrochemicals Summit 2024, 11-12 July 2024, Mumbai

Other Related stories

Startups

Chemical

Petrochemical

Energy

Digitization

Aim to become import substitute for instrumentation business in India
Aim to become import substitute for instrumentation business in India
Vinayak M. Patankar, Sreejith Kumar Whole Time Director & CEO, Borosil Scientific Ltd. , Associate Vice President - Design, Borosil Scientific Ltd.

Looking at increasing manufacturing base outside India
Looking at increasing manufacturing base outside India
Sidharth A. Choksi Executive Vice President, Hindustan Platinum Pvt. Ltd

Developing new products like Vitamin B1 and Vitamin B6
Developing new products like Vitamin B1 and Vitamin B6
Hemal Mehta, Sachin Mehta Chairman, Sudarshan Pharma Industries Ltd. & Managing Director, Sudarshan Pharma Industries Ltd.